- Article metrics
- Last updated: Thu, 2 Apr 2026 15:52:37 Z
An oral, liver-restricted LXR inverse agonist for dyslipidemia: preclinical development and phase 1 trial
Access & Citations
-
- 16k
- Article Accesses
-
- 1
- Citation
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 19 tweeters
- 4 blogs
- 41 news outlets
- 4 Redditors
- 1 Wikipedia page
- 7 Mendeley
This article is in the 99th percentile (ranked 1,118th) of the 343,936 tracked articles of a similar age in all journals and the 91st percentile (ranked 16th) of the 178 tracked articles of a similar age in Nature Medicine
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. The donut visual summarises attention from different sources; a breakdown is shown in the legend. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
First-in-human drug trial lowers high blood fats
EurekAlert! -
First-in-human Drug Trial Lowers High Blood Fats
Mirage News -
First-in-human drug trial lowers high blood fats
MyScience Switzerland -
Takebe Named to TIME100 Health List of Most Influential Leaders
Cincinnati Childrens Science Blog
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.